These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 1017983)
61. [A case of icterus in the course of treatment with rifampicin. Histological records]. Laroche C; Caquet R; Desche-Labarthe S; Fraisse B; Lemaigre G Ann Med Interne (Paris); 1971 Nov; 122(11):1119-22. PubMed ID: 5150312 [No Abstract] [Full Text] [Related]
62. Side effects of rifampicin. A clinical study. Mattson K Scand J Respir Dis Suppl; 1973; 82():1-52. PubMed ID: 4518740 [No Abstract] [Full Text] [Related]
63. How safe is isoniazid? Thompson JE Med J Aust; 1978 Feb; 1(3):165-9. PubMed ID: 651734 [TBL] [Abstract][Full Text] [Related]
64. [Hepatitis induced by combined rifomycin and isoniazid]. Marche J; Hugues FC; Graisely B; Marche C Ann Med Interne (Paris); 1971 Oct; 122(10):1045-54. PubMed ID: 5150725 [No Abstract] [Full Text] [Related]
67. [Synergistic effect of rifampicin on hepatotoxicity of isoniazid]. Skakun NP; Shman'ko VV Antibiot Med Biotekhnol; 1985 Mar; 30(3):185-9. PubMed ID: 4015060 [TBL] [Abstract][Full Text] [Related]
68. [Hepatotoxic side-effects of rifampicin; a comparative clinical study (author's transl)]. Kuntz HD; Rausch V Prax Klin Pneumol; 1977 Nov; 31(11):925-32. PubMed ID: 928291 [No Abstract] [Full Text] [Related]
69. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients]. Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895 [No Abstract] [Full Text] [Related]
70. Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid. Durand F; Bernuau J; Pessayre D; Samuel D; Belaiche J; Degott C; Bismuth H; Belghiti J; Erlinger S; Rueff B Hepatology; 1995 Apr; 21(4):929-32. PubMed ID: 7705802 [TBL] [Abstract][Full Text] [Related]
71. 4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: a meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicity. Ziakas PD; Mylonakis E Clin Infect Dis; 2009 Dec; 49(12):1883-9. PubMed ID: 19911936 [TBL] [Abstract][Full Text] [Related]
72. [Effectiveness of tocopherol and anti-hypoxic agents in liver damage caused by antitubercular agents]. Skakun NP; Slivka IuI Probl Tuberk; 1991; (3):57-9. PubMed ID: 1871097 [TBL] [Abstract][Full Text] [Related]
73. [Frequency, diagnosis, and course of hepatotoxic side effects of Rifampicin (author's transl)]. Deck KA; Gehrhardt A; Klein HO; Ludes H Med Klin; 1976 Oct; 71(43):1836-41. PubMed ID: 995024 [TBL] [Abstract][Full Text] [Related]
75. Fibrinogen and antithrombin III blood levels fluctuations during isoniazid or isoniazid plus rifampicin administration. Farmakis M; Travlou O; Aroni S; Fertakis A Arzneimittelforschung; 1992 Aug; 42(8):1041-4. PubMed ID: 1418078 [TBL] [Abstract][Full Text] [Related]
76. Hepatotoxicity of isoniazid and rifampin in children. Rugmini PS; Mehta S Indian Pediatr; 1984 Feb; 21(2):119-26. PubMed ID: 6469294 [No Abstract] [Full Text] [Related]
77. Hepatitis from isoniazid and rifampin. Groopman JE; Soloff L; Tessler S N Engl J Med; 1978 Jun; 298(23):1316-7. PubMed ID: 651986 [No Abstract] [Full Text] [Related]